A0A6H5HLJ3 · A0A6H5HLJ3_9HEMI

  • Protein
    15-hydroxyprostaglandin dehydrogenase [NAD(+)]
  • Status
    UniProtKB unreviewed (TrEMBL)
  • Amino acids
  • Protein existence
    Inferred from homology
  • Annotation score
    4/5

Function

function

Catalyzes the NAD-dependent dehydrogenation (oxidation) of a broad array of hydroxylated polyunsaturated fatty acids (mainly eicosanoids and docosanoids, including prostaglandins, lipoxins and resolvins), yielding their corresponding keto (oxo) metabolites. Decreases the levels of the pro-proliferative prostaglandins such as prostaglandin E2 (whose activity is increased in cancer because of an increase in the expression of cyclooxygenase 2) and generates oxo-fatty acid products that can profoundly influence cell function by abrogating pro-inflammatory cytokine expression. Converts resolvins E1, D1 and D2 to their oxo products, which represents a mode of resolvin inactivation. Resolvin E1 plays important roles during the resolution phase of acute inflammation, while resolvins D1 and D2 have a unique role in obesity-induced adipose inflammation.

Catalytic activity

  • (11R)-hydroxy-(5Z,8Z,12E,14Z)-eicosatetraenoate + NAD+ = 11-oxo-(5Z,8Z,12E,14Z)-eicosatetraenoate + NADH + H+
    This reaction proceeds in the forward direction.
  • (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + NAD+ = 15-oxo-(5Z,8Z,11Z,13E)-eicosatetraenoate + NADH + H+
    This reaction proceeds in the forward direction.
    EC:1.1.1.232 (UniProtKB | ENZYME | Rhea)
  • 14-hydroxy-(4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoate + NAD+ = 14-oxo-(4Z,7Z,10Z,12E,16Z,19Z)-docosahexaenoate + NADH + H+
    This reaction proceeds in the forward direction.
  • 15-oxo-(5S,6R)-dihydroxy-(7E,9E,11Z)-eicosatrienoate + NADH + H+ = (5S,6R,15S)-trihydroxy-(7E,9E,11Z)-eicosatrienoate + NAD+
    This reaction proceeds in the forward direction.
  • prostaglandin A1 + NAD+ = 15-oxo-prostaglandin A1 + NADH + H+
    This reaction proceeds in the forward direction.
  • prostaglandin E1 + NAD+ = 15-oxoprostaglandin E1 + NADH + H+
    This reaction proceeds in the forward direction.
  • prostaglandin E2 + NAD+ = 15-oxoprostaglandin E2 + NADH + H+
    This reaction proceeds in the forward direction.
    EC:1.1.1.141 (UniProtKB | ENZYME | Rhea)
  • resolvin D1 + NAD+ = 17-oxoresolvin D1 + NADH + H+
    This reaction proceeds in the forward direction.
  • resolvin D1 + NAD+ = 8-oxoresolvin D1 + NADH + H+
    This reaction proceeds in the forward direction.
  • resolvin D2 + NAD+ = 16-oxoresolvin D2 + NADH + H+
    This reaction proceeds in the forward direction.
  • resolvin D2 + NAD+ = 7-oxoresolvin D2 + NADH + H+
    This reaction proceeds in the forward direction.
  • resolvin E1 + NAD+ = 18-oxo-resolvin E1 + NADH + H+
    This reaction proceeds in the forward direction.
  • lipoxin A4 + NAD+ = 15-oxo-(5S,6R)-dihydroxy-(7E,9E,11Z,13E)-eicosatetraenoate + NADH + H+
    This reaction proceeds in the forward direction.

Enzyme and pathway databases

Names & Taxonomy

Protein names

  • Recommended name
    15-hydroxyprostaglandin dehydrogenase [NAD(+)]
  • EC number
  • Alternative names
    • Eicosanoid/docosanoid dehydrogenase [NAD(+)]
    • Prostaglandin dehydrogenase 1

Gene names

    • ORF names
      NTEN_LOCUS22060

Organism names

  • Taxonomic identifier
  • Organism
  • Taxonomic lineage
    Eukaryota > Metazoa > Ecdysozoa > Arthropoda > Hexapoda > Insecta > Pterygota > Neoptera > Paraneoptera > Hemiptera > Heteroptera > Panheteroptera > Cimicomorpha > Miridae > Dicyphina > Nesidiocoris

Accessions

  • Primary accession
    A0A6H5HLJ3

Proteomes

Subcellular Location

Family & Domains

Features

Showing features for region.

TypeIDPosition(s)Description
Region1-25Disordered
Region717-741Disordered

Sequence similarities

Belongs to the short-chain dehydrogenases/reductases (SDR) family.

Family and domain databases

Sequence

  • Sequence status
    Complete
  • Length
    795
  • Mass (Da)
    87,034
  • Last updated
    2020-08-12 v1
  • Checksum
    729C97AAC38478FF
MPAKPDPKLQPKPAGSKTPPTANADRFNLNELKTDVTPEIEKAIASSRTSQLSRLVAFVTGGADGLGKEIVTALAKEGTKVAILDKDPNKGHDLSVELSKNFGRGSVMHFSCDLNDSKSMDTAMKLARTQLGRFDILVNCASCWGDNSETYEKSISLNFKAVVKGSLLAIEYMSATKGGEGGLVANIVDNTAIKPSPLTPVYSATKAAVLKFTTDMGLPQMFNLTKIGFISIMASGITGTQRFDDPEKKIIIPRKELVEPFKENLKTNGAKQSPQHVAEKLISVIKKGEKSGVFLIENVISEVSCKKGATVKPRSAGLHELEVNMAFCPLCSWRQSNDPLINRAIQAFLRPVSFRHANHRVFAISTATAFISLSVSFKIMIYDNFFETTTVALILSGCAALKPVSHVRPFSSPSRRPSGQTDSLLGTLRSMAGSLCNFKLTRCKKSAVYISCWLISIHCAADWKLLAYTDVQSTKMLKLVTILLCLGSALSSDVDTYNGLVDEFLYMATQFMVEYKLDTLSVPNLDIAYDHQKLASWDSVTGTIKTGPGTIVNATGIHRKGDASIELVGDDKMVIKVSIATDPMVITFLKFAIDFSSPWPFSNDGGMQLKVDKNEADIQITFQKAEGVCNLTFDKAEITSLGYIDFLILPDTWWAEVKDKGIDLYVKAHNSDLKTVLNMYLLNILQGVVNKVQPCSEMGSNGQTTGNRHRLNRGNVVSKDERKSGQTACKTTGSSGVRPVRANGPFASRRCRLQSEETHCVSLIRFLPASRNRRCQHHSNQPWMQLTTTASLLKE

Keywords

Sequence databases

Nucleotide SequenceProtein SequenceMolecule TypeStatus
CADCXU010032277
EMBL· GenBank· DDBJ
CAB0018151.1
EMBL· GenBank· DDBJ
Genomic DNA

Similar Proteins

Disclaimer

Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. Our staff consists of biologists and biochemists that are not trained to give medical advice.
We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.
FeedbackHelp